0001209191-18-002238.txt : 20180104
0001209191-18-002238.hdr.sgml : 20180104
20180104190058
ACCESSION NUMBER: 0001209191-18-002238
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180102
FILED AS OF DATE: 20180104
DATE AS OF CHANGE: 20180104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goldberg Jeff Marc
CENTRAL INDEX KEY: 0001703061
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38137
FILM NUMBER: 18511640
MAIL ADDRESS:
STREET 1: C/O AKCEA THERAPEUTICS
STREET 2: 55 CAMBRIDGE PARKWAY, STE 100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001662524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472608175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 55 CAMBRIDGE PARKWAY
STREET 2: SUITE 100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 760-603-2732
MAIL ADDRESS:
STREET 1: 2855 GAZELLE CT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-02
0
0001662524
AKCEA THERAPEUTICS, INC.
AKCA
0001703061
Goldberg Jeff Marc
C/O AKCEA THERAPEUTICS, INC.
55 CAMBRIDGE PARKWAY
CAMBRIDGE
MA
02142
0
1
0
0
Chief Operating Officer
Common Stock
2018-01-01
4
J
0
989
6.80
A
989
D
Stock Option (right to buy)
17.38
2018-01-02
4
A
0
110000
0.00
A
2028-01-01
Common Stock
110000
110000
D
Although not required, the Reporting Person is voluntarily reporting the acquisition of 989 shares on January 1, 2018 pursuant to the Issuer's
Employee Stock Purchase Plan.
The shares vest as follows: 1/4th of the shares vest one year after January 2, 2018; 1/48th of the shares vest monthly thereafter over the next three years.
/s/ Paula Soteropoulos, Attorney-in-Fact
2018-01-04